Loading...
Loading...
AKLI| Name | Value |
|---|---|
| Revenues | 0.1M |
| Cost of Revenue | 0.1M |
| Gross Profit | -0.0M |
| Operating Expense | 24.5M |
| Operating I/L | -24.5M |
| Other Income/Expense | 77.7M |
| Interest Income | 0.0M |
| Pretax | 53.2M |
| Income Tax Expense | -78.2M |
| Net Income/Loss | 131.5M |
Akili, Inc. is a digital medicine company specializing in developing digital therapeutics for cognitive impairments. Their flagship product, EndeavorRx, is a physician-prescribed video game-based treatment that directly targets cognitive functioning. The company generates revenue by selling their digital therapeutics to healthcare providers and patients, who use them as a form of treatment for cognitive impairments.
